|
pubmed:abstractText |
In clinical studies with a new oral antibiotic, lincomycin, excellent results were obtained in the treatment of carbuncles, furuncles, folliculitis, cellulitis, lymphangitis, lymphadenitis, pyonychias and dermatitis infectiosa eczematoides due to coagulase-positive Staphylococcus aureus and to Streptococcus hemolyticus Type A. Encouraging results were noted in a small series of acne conglobata (cystic acne). Loose stools and diarrhea were frequently encountered but these symptoms abated when the dosage was reduced.
|
